烏鴉座製藥公司
DE ˙ DB ˙ US2210151005
€10.25 ↑0.31 (3.12%)
2026-06-04
分享價格
SecurityDE:C17 / Corvus Pharmaceuticals, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership2,498,825 shares
Latest Disclosed Value $ 36,557,808
Morgan Stanley reports 29.96% decrease in ownership of C17 / Corvus Pharmaceuticals, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 2,498,825 shares of Corvus Pharmaceuticals, Inc. (DE:C17) valued at $28,336,676 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 3,567,908 shares of Corvus Pharmaceuticals, Inc.. This represents a change in shares of -29.96% during the quarter. The current value of the position is $25,612,956 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 2,498,825 -1,069,083 -29.96 36,558 33.07 0.0022
2026-05-27 2025-12-31 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 3,567,908 2,950,684 478.06 27,473 504.05 0.0016
2026-02-13 2025-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 3,567,908 2,950,684 27,473 0.0016
2026-05-27 2025-09-30 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 617,224 -277,181 -30.99 4,549 27.15 0.0003
2025-11-14 2025-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 617,224 -277,181 4,549 0.0003
2025-08-15 2025-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 894,405 220,881 32.79 3,578 67.07 0.0002
2025-05-15 2025-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 673,524 276,160 69.50 2,142 0.75 0.0002
2025-05-15 2024-12-31 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 397,364 4,102 1.04 2,126 2.36 0.0001
2025-02-14 2024-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 397,364 4,102 2,126 0.0001
2025-05-14 2024-09-30 13F/A-2 CORVUS PHARMACEUTICALS COM 221015100 393,262 21,859 5.89 2,076 207.56 0.0002
2025-02-14 2024-09-30 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 393,262 21,859 2,076 0.0002
2024-11-14 2024-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 393,262 21,859 2,076 0.0002
2025-05-14 2024-06-30 13F/A-2 CORVUS PHARMACEUTICALS COM 221015100 371,403 96,042 34.88 676 37.76 0.0001
2024-10-17 2024-06-30 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 371,403 96,042 676 0.0001
2024-08-14 2024-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 371,403 96,042 676 0.0001
2024-10-17 2024-03-31 13F/A-2 CORVUS PHARMACEUTICALS COM 221015100 275,361 15,706 6.05 490 7.46 0.0000
2024-08-16 2024-03-31 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 275,361 15,706 490 0.0000
2024-05-15 2024-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 275,361 15,706 490 0.0000
2024-08-16 2023-12-31 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 259,655 67,149 34.88 457 62.28 0.0000
2024-02-13 2023-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 259,655 67,149 457 0.0000
2023-11-15 2023-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 192,506 52,871 37.86 281 -11.91 0.0000
2023-08-14 2023-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 139,635 39,476 39.41 320 250.55 0.0000
2023-05-15 2023-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 100,159 27,554 37.95 91 49.18 0.0000
2023-02-14 2022-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 72,605 33,288 84.67 62 90.63 0.0000
2022-11-14 2022-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 39,317 -10,031 -20.33 32 -34.69 0.0000
2022-10-27 2022-06-30 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 49,348 8,486 20.77 49 -26.87 0.0000
2022-08-15 2022-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 49,348 8,486 49 0.0000
2022-10-27 2022-03-31 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 40,862 3,986 10.81 67 -23.86 0.0000
2022-05-13 2022-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 40,862 3,986 67 0.0000
2022-02-14 2021-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 36,876 6,933 23.15 88 -39.31 0.0000
2021-11-15 2021-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 29,943 -7,181 -19.34 145 46.46 0.0000
2021-08-23 2021-06-30 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 37,124 -129 -0.35 99 -13.91 0.0000
2021-08-16 2021-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 37,124 -129 99 0.0000
2021-05-17 2021-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 37,253 -690 -1.82 115 -14.81 0.0000
2021-02-16 2020-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 37,943 5,197 15.87 135 3.05 0.0000
2020-11-13 2020-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 32,746 17,704 117.70 131 219.51 0.0000
2020-08-14 2020-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 15,042 -17,878 -54.31 41 -40.58 0.0000
2020-05-26 2020-03-31 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 32,920 -5,708 -14.78 69 -67.14 0.0000
2020-05-15 2020-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 32,920 -5,708 69 18.7170
2020-02-14 2019-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 38,628 -6,744 -14.86 210 54.41 0.0000
2019-11-14 2019-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 45,372 12,741 39.05 136 11.48 0.0000
2019-08-14 2019-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 32,631 -24,668 -43.05 122 -46.96 0.0000
2019-05-15 2019-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 57,299 23,113 67.61 230 82.54 0.0001
2019-02-14 2018-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 34,186 10,394 43.69 126 -38.24 0.0000
2019-04-23 2018-09-30 13F/A-2 CORVUS PHARMACEUTICALS COM 221015100 23,792 -7,177 -23.17 204 -40.00 0.0001
2018-11-20 2018-09-30 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 23,792 0 204 0.0001
2018-11-14 2018-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 23,792 -7,177 204
2019-04-23 2018-06-30 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 30,969 6,621 27.19 340 21.00 0.0001
2018-08-14 2018-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 30,969 6,621 340
2019-04-23 2018-03-31 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 24,348 6,275 34.72 281 50.27 0.0001
2018-05-14 2018-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 24,348 6,275 281
2019-04-23 2017-12-31 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 18,073 3,937 27.85 187 -17.26 0.0001
2018-02-14 2017-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 18,073 3,937 187
2017-11-14 2017-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 14,136 5,216 58.48 226 107.34 0.0001
2017-08-11 2017-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 8,920 4,205 89.18 109 11.22 0.0000
2017-05-22 2017-03-31 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 4,715 -5,256 -52.71 98 -30.99 0.0000
2017-05-12 2017-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 4,715 98
2017-02-22 2016-12-31 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 9,971 9,063 998.13 142 846.67 0.0000
2017-02-13 2016-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 9,971 142
2016-11-10 2016-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 908 908 -90.89 15 -89.44 0.0000
2016-08-12 2016-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 0 -219 -100.00 0 -100.00
2016-05-12 2016-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 219 219 3 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.